专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

71. 发明申请

US20100135264A1 Communication Method under IEEE 802.11e Enhanced Distributed Channel Access 审中-公开
标题翻译： IEEE 802.11e增强分布式信道接入下的通信方法
公开(公告)号：US20100135264A1
公开(公告)日：2010-06-03
申请号：US12326460
申请日：2008-12-02
申请人： Thomas Nilsson
发明人： Thomas Nilsson
IPC分类号： H04W4/00
CPC分类号： H04W74/08 , H04W74/0816 , H04W74/0833 , H04W84/12
摘要： The present invention provides a method for the Medium Access Control (MAC) layer in IEEE 802.11e Enhanced Distributed Channel Access (EDCA) to improve its performance. Contention parameters are used in EDCA to provide Quality of Service (QoS). However, these parameters are only good for low number of senders and there is a need to adjust the parameters dynamically when the network conditions changes. The present invention enhances the throughput for each priority class and makes it stable and almost independent to the total number of senders in the network. Hence, the need of adapting the contention parameters is not longer required. The present invention also provides capacity for a priority class that is directly proportional to the contention parameters used.
摘要翻译：本发明提供了一种用于IEEE 802.11e增强分布式信道接入（EDCA）中的媒体接入控制（MAC）层的方法，以提高其性能。 EDCA中使用争用参数来提供服务质量（QoS）。然而，这些参数只对低数量的发送者有好处，并且需要在网络条件变化时动态地调整参数。本发明增强了每个优先级的吞吐量，使其稳定并且几乎独立于网络中的发送者总数。因此，不再需要适应争用参数。本发明还提供与所使用的竞争参数成正比的优先级的容量。

72. 外观设计

USD551054S1 Bicycle bar grip 有权
标题翻译：自行车把手
公开(公告)号：USD551054S1
公开(公告)日：2007-09-18
申请号：US29257071
申请日：2006-03-29
申请人： Peter Eijvinsoon , Anna Carell , Thomas Nilsson , Franc Arnold , Kim Tofaute
设计人： Peter Eijvinsoon , Anna Carell , Thomas Nilsson , Franc Arnold , Kim Tofaute

73. 发明申请

US20070068524A1 Inhaler for moisture sensitive drugs 审中-公开
标题翻译：吸入水分敏感的药物
公开(公告)号：US20070068524A1
公开(公告)日：2007-03-29
申请号：US11255011
申请日：2005-10-21
申请人： Thomas Nilsson , Lars Holwaster
发明人： Thomas Nilsson , Lars Holwaster
IPC分类号： A61M15/00 , A61M16/10
CPC分类号： A61M15/00 , A61M2202/064
摘要： A dry powder inhaler device (DPI) is disclosed. When a user activates the inhaler, the DPI is capable of delivering a dry powder dose directly from a medicament container, loaded into the DPI. A method is also disclosed for delivering a dry powder medicament dose directly from a container to a user of a DPI, whereby a sealing foil of the container is being slit open concurrently with aerosolizing and entraining of the powder in the dose into the inhaled air.
摘要翻译：公开了一种干粉吸入器装置（DPI）。当用户激活吸入器时，DPI能够直接从装载到DPI中的药物容器输送干粉剂量。还公开了一种用于将干粉药物剂量直接从容器输送到DPI的使用者的方法，由此容器的密封箔同时切开，同时将粉末雾化并夹带入吸入空气中。

74. 发明申请

US20060120969A1 Medical product for inhalation containing glucagon-like peptide-1 (GLP-1) 审中-公开
标题翻译：含有胰高血糖素样肽-1（GLP-1）的吸入医药产品
公开(公告)号：US20060120969A1
公开(公告)日：2006-06-08
申请号：US11049696
申请日：2005-02-04
申请人： Thomas Nilsson , Sven Calander , Alf Niemi , Claes Friberg , Lars Kax , Mattias Myrman
发明人： Thomas Nilsson , Sven Calander , Alf Niemi , Claes Friberg , Lars Kax , Mattias Myrman
IPC分类号： A61K38/26 , A61K9/14 , A61L9/04
CPC分类号： A61K9/0075 , A61K38/26
摘要： A medical product containing an accurately metered dose of a GLP-1 medicament intended for pulmonary inhalation put into a moisture-tight, high barrier seal container. The medical product optionally also contains a dose of insulin. The container is preferably adapted for application into a dry powder inhaler. The dose loaded in the container is intended for a prolonged delivery by inhalation to the deep lung where the active ingredients are absorbed into the system. Optionally the medical product also may comprise at least one biologically acceptable excipient.
摘要翻译：含有准确计量剂量的用于肺部吸入的GLP-1药物的医疗产品放入防潮密封的高屏障密封容器中。医疗产品任选还含有一定剂量的胰岛素。容器优选适于施用于干粉吸入器中。装载在容器中的剂量旨在通过吸入长时间地输送到深肺，其中活性成分被吸收到系统中。任选地，医疗产品还可以包含至少一种生物可接受的赋形剂。

75. 发明申请

US20050231833A1 Optical component 失效
标题翻译：光学元件
公开(公告)号：US20050231833A1
公开(公告)日：2005-10-20
申请号：US10514629
申请日：2003-05-28
申请人： Magnus Carlsson , Thomas Nilsson , Par Ragnarsson , Lars-Ake Larsson , Jorgen Malmborg
发明人： Magnus Carlsson , Thomas Nilsson , Par Ragnarsson , Lars-Ake Larsson , Jorgen Malmborg
IPC分类号： G01N21/27 , G02B5/00 , G02B27/14 , G02B5/08
CPC分类号： G02B27/126
摘要： A passive optical component directs first electromagnetic radiation incident on the component in a first direction and second electromagnetic radiation incident on the component in a second direction to a mutual direction. The optical component comprises an interacting surface which is arranged to interact with said first and second electromagnetic radiation. The interacting surface comprises first portions, each having a surface extending in a third direction, which is essentially perpendicular to the mutual direction, and second portions, each having a surface extending in a fourth direction. The optical component reflects essentially all the first electromagnetic radiation and transmits at least a significant portion of the second electromagnetic radiation for directing the first and the second electromagnetic radiation to a mutual direction. An optical system and a method using the passive optical component are also shown.
摘要翻译：无源光学部件将沿第一方向入射到部件上的第一电磁辐射和沿相反方向的第二方向入射到部件上的第二电磁辐射。光学部件包括被配置为与所述第一和第二电磁辐射相互作用的相互作用表面。相互作用的表面包括第一部分，每个部分具有在基本上垂直于相互方向的第三方向上延伸的表面，以及第二部分，每个部分具有在第四方向上延伸的表面。光学部件基本上反射所有第一电磁辐射，并且透射至少大部分的第二电磁辐射，用于将第一和第二电磁辐射引向相互的方向。还示出了使用无源光学部件的光学系统和方法。

76. 发明申请

US20050123486A1 Medical product containing tiotropium 审中-公开
标题翻译：含噻托溴铵的医药产品
公开(公告)号：US20050123486A1
公开(公告)日：2005-06-09
申请号：US10921192
申请日：2004-08-19
申请人： Thomas Nilsson , Mattias Myrman , Sven Calander , Alf Niemi
发明人： Thomas Nilsson , Mattias Myrman , Sven Calander , Alf Niemi
IPC分类号： A61K9/00 , A61K31/4745 , A61L9/04 , A61K9/14
CPC分类号： A61K9/0075 , A61K31/439
摘要： The invention discloses a medical product that may be used in a treatment of respiratory disorders.
摘要翻译：本发明公开了一种可用于治疗呼吸系统疾病的医疗产品。

77. 发明申请

US20050121026A1 Method for administration of tiotropium 审中-公开
标题翻译：噻托溴铵的给药方法
公开(公告)号：US20050121026A1
公开(公告)日：2005-06-09
申请号：US10729024
申请日：2003-12-08
申请人： Thomas Nilsson , Mattias Myrman , Sven Calander , Alf Niemi
发明人： Thomas Nilsson , Mattias Myrman , Sven Calander , Alf Niemi
IPC分类号： A61K9/00 , A61K31/4745 , A61M15/00 , A61L9/04 , A61K9/14 , A61M11/00
CPC分类号： A61K9/0075 , A61K31/439 , A61K31/4745 , A61M15/0028 , A61M2202/064
摘要： A method for administration and preparation of pharmaceutical dry powder doses are disclosed. The metered dry powder doses are formed from a finely divided dry powder of an selected anticholinergic agent to be used in a dry powder inhaler device. The metered dry powder medicinal dose is arranged as a medicinally effective quantity of the selected medicament onto a dose bed and moisture-tight sealed by using a high barrier seal, for introduction into an inhaler device provided with an Air-razor device for obtaining a fine particle fraction, FPF, of at least 30-50% of delivered powder mass when suction through the inhaler is applied, whereby the dose is delivered to and deposited in the lung of the user during a single inhalation effort.
摘要翻译：公开了用于药物干粉剂量的给药和制备的方法。计量的干粉剂量由干粉吸入器装置中使用的选择的抗胆碱剂的细碎干粉形成。计量的干粉药物剂量被设置为药物有效量的所选择的药物到剂量床上，并通过使用高阻隔密封件进行防潮密封，以引入设置有用于获得罚款的空气剃刀装置的吸入器装置当通过吸入器吸入时，粒子分数FPF为输送粉末质量的至少30-50％，从而在单次吸气过程中将剂量输送给用户并沉积在使用者的肺部。

78. 发明授权

US06696090B1 Electro-powder 失效
标题翻译：电粉
公开(公告)号：US06696090B1
公开(公告)日：2004-02-24
申请号：US09636548
申请日：2000-08-11
申请人： Thomas Nilsson , Lars-Gunnar Nilsson
发明人： Thomas Nilsson , Lars-Gunnar Nilsson
IPC分类号： A61K914
CPC分类号： A61K9/0075 , A61K9/0009 , A61M15/02 , A61M2202/064
摘要： A method and a process are disclosed for preparation of medical electro-powders. The electro-powder results from preparations of chemical and biological substances to form electro-powders suitable for electrostatic charging and dosing for functionality in a dry powder inhaler device. The electro-powder resulting from the method and process forms an active powder substance or a dry powder medical formulation with a fine particle fraction representing of the order 50% or more of the content having a size ranging between 0.5-5 &mgr;m and provides electrostatic properties with an absolute specific charge per mass after charging of the order 0.1×10−6 to 25×10−6 C/g and presenting a charge decay rate constant Q50>0.1 sec with a tap density of less than 0.8 g/ml and a water activity aw of less than 0.5. In the processing the active substance is a generally pharmaceutical active chemical or biological substance, for instance a polyeptide or any other corresponding substance selected alone or mixed or blended together with one or more excipients being a compound to improve electrostatic properties of the medical dry powder substance or dry powder medical formulation. Further the electro-powder may even be formed as a micro-encapsulation by coating micronized powder with the excipient in such a way that the active substance is capsulated, whereby the powder electrostatic properties mainly comes from the excipient.
摘要翻译：公开了用于制备医用电子粉末的方法和方法。电粉由化学和生物物质的制备产生，以形成适于静电充电的电粉和在干粉吸入器装置中用于功能的剂量。由该方法和方法得到的电粉形成活性粉末物质或干粉医药制剂，其细颗粒级分表示尺寸范围在0.5-5μm之间的含量的50％以上，并提供静电特性在0.1×10 -6至25×10 -6 C / g的量的充电之后具有绝对的特定电荷/质量，并且具有小于0.8g / ml的振实密度的电荷衰减速率常数Q 50> 0.1秒，水分活度小于0.5。在加工过程中，活性物质是通常为药物活性的化学或生物物质，例如单独选择或与一种或多种赋形剂混合或混合在一起的多肽或任何其它相应的物质，以提高医用干粉物质的静电特性或干粉医药制剂。此外，电子粉末甚至可以通过用赋形剂涂覆微粉化粉末以使活性物质被包封的方式形成为微胶囊，由此粉末静电性质主要来自赋形剂。

79. 发明授权

US06571793B1 Optimization of an electrostatically dosed dry powder inhaler 失效
标题翻译：静电剂干粉吸入器的优化
公开(公告)号：US06571793B1
公开(公告)日：2003-06-03
申请号：US09688697
申请日：2000-10-17
申请人： Thomas Nilsson
发明人： Thomas Nilsson
IPC分类号： A61M1500
CPC分类号： A61M15/02 , A61M15/0028 , A61M15/0083 , A61M2016/0039 , A61M2202/064
摘要： A method and a process are disclosed for optimizing an electrostatically dosed dry powder inhaler (EDPI) for utilization of a prepared pre-metered electro-dose consisting of a electro-powder. An arrangement is set-up for measuring parameters affecting a systemic delivery or local lung delivery of a pre-metered electro-dose from and DPI including analysis of dose de-agglomeration, particle size distribution as well as dose-to-dose variation together with pressures times and flows. A dry powder inhaler, DPI, is adjusted for a systemic or a local lung setting with respect to activation pressure and closing pressure having a DPI with a 20 to 60 liters/minute inhalation air flow for systemic delivery setting and 20 to 80 liters/minute for a local lung setting. Furthermore the de-agglomeration power is adjusted between 0.1 and 6 watts to be used in the DPI by optimizing the pressure drop and inhalation flow rate by changes to the mouthpiece and/or the device member and their relation to each other. The DPI activation pressure is further adjusted to a value between 0.5 and 4 kPa and closing pressure between 0.5 and 4 kPa to eliminate the low power at the start and end of the inhalation. The method and process then verify that the DPI meets the specifications set regarding de-agglomeration of power and opening and closing pressures together with timings within the DPI active time. Furthermore is verified that de-agglomeration difference, expressed in percent using an expression 100[1-de-agglomeration(Q1 kPa)/de-agglomeration(Q)], is not more than 50%. Finally if the DPI is not approved as an EDPI the tested DPI and/or electro-dose is further adjusted to check if the DPI can meet the specifications of an EDPI.
摘要翻译：公开了一种方法和方法，用于优化静电计量干粉吸入器（EDPI），以利用由电粉组成的制备的预计量的电子剂量。设置了用于测量影响来自和DPI的预计量的电子剂量的系统递送或局部肺输送的参数的装置，包括剂量去附聚，粒度分布以及剂量与剂量变化的分析以及剂量 - 剂量变化压力时间和流量。相对于具有DPI的活化压力和闭合压力，对于全身或局部肺设置调整干粉吸入器DPI，其具有用于全身输送设定的20至60升/分钟吸入空气流和20至80升/分钟用于局部肺部设置。此外，通过通过对接口管和/或设备构件的改变以及它们彼此之间的关系来优化压降和吸入流量，DPD中使用去聚集功率在0.1至6瓦特之间进行调整。 DPI活化压力进一步调整为0.5-4 kPa之间的值，关闭压力在0.5至4 kPa之间，以消除吸入开始和结束时的低功率。然后，该方法和过程验证DPI满足关于功率和开启和关闭压力的解聚集的规范以及DPI活动时间内的定时。此外，证明使用表达式100 [1-去聚集（Q1kPa）/去聚集（Q）]表示的去聚集差异不大于50％。最后，如果DPI未被批准为EDPI，则进一步调整测试的DPI和/或电子剂量，以检查DPI是否可以满足EDPI的规格。

80. 发明授权

US06199284B1 Metal shears with mechanical advantage 失效
标题翻译：金属剪有机械优势
公开(公告)号：US06199284B1
公开(公告)日：2001-03-13
申请号：US09274884
申请日：1999-03-23
申请人： Thomas Nilsson , Håkan Bergkvist , Frederic Delaunay
发明人： Thomas Nilsson , Håkan Bergkvist , Frederic Delaunay
IPC分类号： B26B1306
CPC分类号： B26B13/26 , B23D29/026
摘要： Shears for cutting metal sheet include first and second jaws pivotably interconnected by a jaw joint. The jaws have respective cutting edges located forwardly of the jaw joint, and which are arranged to cross one another at a crossing point which moves during a cutting operation. The cutting edges are configures to cross one another at a substantially constant angle during a cutting operation. The second jaw includes an extension extending rearwardly of the jaw joint. The first jaw has a rigidly attached first gripping handle. A second gripping handle is pivotably connected to the first handle by a handle joint located rearwardly of the jaw joint. The second handle engages a surface of the extension by a sliding contact, whereby a distance between the jaw joint and the sliding contact increases during a cutting operation.
摘要翻译：用于切割金属板的剪切包括通过爪接头可枢转地互连的第一和第二夹爪。夹爪具有位于钳口接合部的前方的相应的切削刃，并且它们被布置为在切割操作期间移动的交叉点处彼此交叉。切割边缘是在切割操作期间以基本上恒定的角度彼此交叉的构造。第二钳口包括从钳口接头向后延伸的延伸部。第一颚具有刚性附接的第一夹持把手。第二把手通过位于颚关节后面的手柄关节可枢转地连接到第一手柄。第二把手通过滑动接触件与延伸部的表面接合，由此在切割操作期间，爪接头和滑动接触件之间的距离增加。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式